MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease

B C Dickerson1, I Goncharova, M P Sullivan

  • 1Department of Neurological Sciences, Rush University, Chicago, IL 60612, USA.

Neurobiology of Aging
|November 14, 2001
PubMed

Insights

Early Alzheimer's disease (AD) detection is possible using MRI brain scans. Entorhinal cortex volume, not hippocampal volume, best predicts conversion to AD in patients with cognitive complaints.

Area of Science:

  • Neurology
  • Radiology
  • Neuroimaging

Background:

  • Alzheimer's disease (AD) diagnosis relies on identifying early anatomical changes in the brain.
  • High-resolution magnetic resonance imaging (MRI) enables in vivo examination of brain structures.

Purpose of the Study:

  • To compare entorhinal and hippocampal volumes in healthy controls, patients with cognitive complaints, and those with very mild AD.
  • To determine if entorhinal or hippocampal volume better predicts conversion to AD.

Main Methods:

  • Quantitative MRI was used to measure entorhinal and hippocampal volumes.
  • Comparison of regional brain volumes across three groups: healthy elderly controls, non-demented patients with cognitive complaints, and very mild AD patients.

Main Results:

  • Both non-demented and very mild AD groups showed reduced entorhinal volume compared to controls, with no significant difference between patient groups.
  • Hippocampal volume was significantly reduced in both patient groups compared to controls, with the greatest atrophy observed in the very mild AD group.
  • Follow-up revealed 12/23 non-demented patients converted to AD; entorhinal volume, not hippocampal volume, differentiated converters from non-converters.

Conclusions:

  • Both entorhinal cortex (EC) and hippocampus degenerate before overt dementia symptoms appear.
  • Entorhinal cortex volume is a more sensitive predictor of future Alzheimer's disease conversion than hippocampal volume.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...